Ruby Hirose (1904–1960): A Pioneer in Biochemistry and Vaccine Research
Ruby Hirose was a trailblazing Japanese-American biochemist and microbiologist whose research during the mid-20th century provided critical insights into blood coagulation, allergy treatments, and the development of vaccines for major diseases, including polio. Despite the profound racial and gender barriers of her era—and the incarceration of her family during World War II—Hirose established herself as a formidable scientist whose work saved lives and pushed the boundaries of medical chemistry.
1. Biography: Early Life, Education, and Career Trajectory
Early Life & Roots
Ruby Hirose was born on August 23, 1904, in Kent, Washington. She was the daughter of Shusaku and Tome Hirose, Japanese immigrants who established a farm in the White River Valley. One of seven children, Ruby grew up in a community of Nisei (second-generation Japanese Americans) who prioritized education as a means of social mobility.
Academic Journey
Hirose’s academic path was marked by rapid advancement in a field dominated by men:
- Undergraduate: She attended the University of Washington, earning a Bachelor of Science in Pharmacy in 1926.
- Graduate: She continued at the University of Washington, completing her Master’s degree in Pharmacology in 1928. Her thesis focused on the pharmacological properties of Caulophyllum thalictroides (Blue Cohosh).
- Doctorate: Hirose moved to the University of Cincinnati, where she earned her Ph.D. in Biochemistry in 1932. She was one of the first Japanese-American women to earn a doctorate in the sciences.
Career Trajectory
Following her Ph.D., Hirose remained at the University of Cincinnati for several years as a research fellow. In the late 1930s, she transitioned into the private sector, joining the William S. Merrell Company as a researcher. It was here that she conducted her most famous work on vaccines.
Later in her career, Hirose moved to the public sector, working for the Microbiological Institute of the National Institutes of Health (NIH) and later serving as a researcher for the Veterans Administration Hospital in Dayton, Ohio, where she focused on cancer research.
2. Major Contributions: Discoveries and Methodologies
Ruby Hirose’s research spanned several critical areas of human health:
- Infantile Paralysis (Polio) Vaccine: Hirose is most frequently cited for her contributions to the development of a vaccine against poliomyelitis. Working at the Merrell Company, she focused on improving the methods for culturing and attenuating the virus. Her work contributed to the foundational knowledge that Jonas Salk and Albert Sabin would later use to finalize effective vaccines in the 1950s.
- Blood Coagulation and Thrombin: In the 1930s, Hirose conducted sophisticated biochemical studies on the nature of thrombin—the enzyme in blood plasma that causes the clotting of blood by converting fibrinogen to fibrin. Her research helped clarify the chemical reactions necessary for blood to clot, which was vital for surgery and trauma medicine.
- Allergy and Immunology: Hirose performed extensive research on "pollen antigens." She investigated how individuals developed sensitivities to hay fever and explored ways to improve desensitization treatments (allergy shots) by refining the chemical composition of the extracts used.
- Cancer Research (Antimetabolites): In her final years, she studied the effects of antimetabolites on cancer cells. This research aimed to disrupt the DNA synthesis of malignant cells, a precursor to modern chemotherapy techniques.
3. Notable Publications
While many of her findings were proprietary to the laboratories where she worked, several of her academic papers remain benchmarks in early biochemistry:
- "The Nature of Thrombin" (1934): Published in The American Journal of Physiology, this paper detailed her findings on the purification and chemical behavior of thrombin.
- "The Diffusion of Sulfonamides, P-Aminobenzoic Acid, and Urea into Fibrin Clots" (1945): This study explored how drugs penetrate blood clots, which had significant implications for treating infections within the vascular system.
- "Pharmacological Action of Glucoside of Caulophyllum Thalictroides" (1928): Her early work on botanical pharmacology, exploring the medicinal properties of plants.
4. Awards & Recognition
In an era when women—especially those of Asian descent—were rarely highlighted in the press, Hirose’s brilliance earned her public notice:
- American Chemical Society Recognition (1940): At a major ACS meeting in Cincinnati, Hirose was one of ten women chemists honored for their significant contributions to the field. This was a rare distinction for a Nisei woman during a period of rising anti-Japanese sentiment.
- Sigma Xi Membership: She was elected to Sigma Xi, the Scientific Research Honor Society, a prestigious appointment reserved for those who have shown excellence in scientific investigation.
5. Impact & Legacy
Ruby Hirose’s legacy is twofold: scientific and social.
Scientific Impact:
Her work on vaccines occurred during a period of intense public fear regarding polio. By refining the biochemical processes behind vaccine production, she helped accelerate the timeline for one of the 20th century’s greatest medical triumphs. Her work on blood clotting also provided a more rigorous chemical understanding of hematology that benefited both physiological research and clinical practice.
Social Legacy:
As one of the first Japanese-American women to break into high-level industrial and academic chemistry, she served as a quiet but powerful symbol of resilience. Today, she is frequently cited by organizations promoting Women in STEM and AAPI (Asian American and Pacific Islander) history, representing the often-overlooked contributions of minority scientists during the mid-century.
6. Collaborations and Affiliations
- The William S. Merrell Company: This pharmaceutical firm was Hirose’s primary research home during her most productive years in vaccine development.
- University of Cincinnati Medical College: She collaborated with various faculty members on biochemical research, bridge-building between the chemistry department and the medical school.
- National Institutes of Health (NIH): Her tenure at the NIH placed her at the center of American public health research during the post-WWII era.
7. Lesser-Known Facts: The Internment Paradox
The most poignant aspect of Ruby Hirose’s life is the "Internment Paradox." In 1942, following the signing of Executive Order 9066, Hirose’s father, brother, and sisters were forcibly removed from their homes and sent to the Minidoka Relocation Center in Idaho.
Because Ruby was living and working in Cincinnati, Ohio—which was outside the "exclusion zone" of the West Coast—she was not interned. While her family lived behind barbed wire in the desert, Ruby was in the lab, working on vaccines to protect the American public from polio. This stark contrast highlights the profound irony of her position: a scientist dedicated to saving the lives of a nation that had deemed her family "enemy aliens."
Ruby Hirose passed away on October 7, 1960, in Reading, Pennsylvania. She is buried in her hometown of Kent, Washington, where she is remembered not just as a local daughter, but as a pioneer of modern medicine.